share_log

Citigroup Initiates Coverage On Alpha Tau Medical With Buy Rating, Announces Price Target of $8

Benzinga ·  Dec 15, 2023 09:43

Citigroup analyst Ashiq Mubarack initiates coverage on Alpha Tau Medical (NASDAQ:DRTS) with a Buy rating and announces Price Target of $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment